A recent report published by Infinium Global Research on the vaccine vials market provides an in-depth analysis of segments and sub-segments in the global as well as regional vaccine vials market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional vaccine vials market over the short term as well as long term. The report is a comprehensive presentation of trends, forecasts, and dollar values of the global vaccine vials market. According to the report, the global vaccine vials market is projected to grow at a CAGR of 15.67% from USD 3561 million in 2020 to over USD 8530 million in 2026 during the forecast period of 2020-2026.
The invention of vaccines has revolutionized the healthcare
scenario across the world. Vaccines strengthen the immune system by exposing it
to weaker pathogens. The enhanced immune system then protects the human body
from infections and diseases. The commercially available vaccines are packaged
in vials or ampoules, which are then administered through injections. The
vaccine manufacturers prefer the small size of vials for packaging in order to
produce a large amount of vaccine. At the same time, vaccines are administered
in smaller dosages compared to other drugs, which makes smaller-sized vails a
better packaging option. Moreover, vaccine vials are available in either
plastic or glass material. Furthermore, the vaccine vials could differ in
design depending upon their use including single dosage or multiple doses. The
market players offer a wide variety of vials for vaccine packaging.
The spread of coronavirus has led to the rise in the number
of research activities to develop a vaccine to cure as well as prevent healthy
people from infection. Several vaccine manufacturers across the world have
increased their research capacity to find an effective vaccine against the
coronavirus. Moreover, COVID19 has affected millions of people around the
world, which is expected to generate huge demand for vaccines. Higher demand
for vaccines is set to put pressure on the manufacturers as well as healthcare
professionals to supply the vaccine. This, in turn, is anticipated to boost the
demand for vials, once the vaccine is commercially available and all set to be
mass-produced. However, the transport of raw materials and finished goods has
disrupted during the pandemic, which is expected to be the major challenge
during the short term.
The growing number of initiatives from government and
private organizations to promote immunization is the major drivers for the
vaccine vials market. Several governments around the world, particularly in
developing countries, have undertaken immunization programs to eradicate
certain communicable diseases. Under such immunization programs, healthcare
organizations procure vaccines in a large amount. This, in turn, increases the
demand for a large number of vaccines, boosting the sale of vaccine vials.
Moreover, the growing awareness among the people regarding endemic diseases
is expected to augment the market growth. The population is being made aware of
the benefits of immunization through its promotion and education. However, the
poor healthcare infrastructure in some of the developing regions in the world
is the major restrain for market growth. Nevertheless, the development of
innovative vaccine administration methods is expected to offer business
opportunities during the forecast period.
In terms of geography, North America generated the highest
revenue for the vaccine vials market in 2019. The countries including the US
and Canada are the major contributors to the higher revenue from the vaccine
vials market in North America. The higher spending capacity on healthcare is mainly
supporting the domination of North America in the global market. Moreover, the
presence of several leading vaccine manufacturers in the region is expected to
augment the demand for vaccine vials over the forecast period. Furthermore,
the Asia Pacific region is expected to register the highest growth rate owing
to a rise in the trend of contract manufacturing.
The report on the global vaccine vials market covers
segments such as type, material, and capacity. On the basis of type, the
sub-markets include single dose and multi-dose. On the basis of material, the
sub-markets include glass and polymer. On the basis of capacity, the sub-markets
include 2ml, 3ml, 5ml, 10ml, and 20ml.
The report provides profiles of the companies in the market
such as Cardinal Health, Inc., Berlin Packaging LLC, SCHOTT AG, Richland Glass
Company, Inc., Gerresheimer AG, Thermo Fisher Scientific Inc, Catalent, Inc.,
Nipro Corporation, DWK Life Sciences GmbH, and Vetter Pharma-Fertigung GmbH
& Co. KG.
The report provides deep insights into the demand forecasts,
market trends, and micro and macro indicators. In addition, this report
provides insights into the factors that are driving and restraining the growth
in this market. Moreover, The IGR-Growth Matrix analysis given in the report
brings an insight into the investment areas that existing or new market players
can consider. The report provides insights into the market using analytical
tools such as Porter's five forces analysis and DRO analysis of the vaccine
vials market. Moreover, the study highlights current market trends and provides
forecasts from 2020-2026. We also have highlighted future trends in the market
that will affect the demand during the forecast period. Moreover, the
competitive analysis given in each regional market brings an insight into the
market share of the leading players.
Please Choose One of them.